Review: Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer

by Fotios Loupakis, Chiara Cremolini, Gabriella Fontanini, Irene Stasi, Lisa Salvatore, Alfredo Falcone
Published 2009-11-01

A Novel <i>ATM</i> Pathogenic Variant in an Italian Woman with Gallbladder Cancer

by Elisa De Paolis, Andrea Urbani, Lisa Salvatore, Laura Foca, Giampaolo Tortora, Angelo Minucci, Paola Concolino
Published 2021-02-01

Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification

by Vincenzo Nasca, Marta Chiaravalli, Geny Piro, Annachiara Esposito, Lisa Salvatore, Giampaolo Tortora, Vincenzo Corbo, Carmine Carbone
Published 2020-09-01

PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target

by Lisa Salvatore, Maria Alessandra Calegari, Fotios Loupakis, Matteo Fassan, Brunella Di Stefano, Maria Bensi, Emilio Bria, Giampaolo Tortora
Published 2019-11-01

Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection

by Francesco Ardito, Francesco Razionale, Lisa Salvatore, Tonia Cenci, Maria Vellone, Michele Basso, Elena Panettieri, Maria Alessandra Alessandra Calegari, Giampaolo Tortora, Maurizio Martini, Felice Giuliante
Published 2021-04-01

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association

by Chiara Cremolini, Michela Cinquini, Lisa Salvatore, Marco Imperatori, Ermenegildo Arnoldi, Carlo Carnaghi, Maurizio Cosimelli, Stefania Sciallero, Renato Cannizzaro, Daniela Musio, Ivan Moschetti, Veronica Andrea Fittipaldo, Giuseppe Aprile, Giordano D Beretta
Published 2020-12-01

Challenges in Crohn’s Disease Management after Gastrointestinal Cancer Diagnosis

by Claudio Fiorillo, Carlo Alberto Schena, Giuseppe Quero, Vito Laterza, Daniela Pugliese, Giuseppe Privitera, Fausto Rosa, Tommaso Schepis, Lisa Salvatore, Brunella Di Stefano, Luigi Larosa, Laura Maria Minordi, Luigi Natale, Giampaolo Tortora, Alessandro Armuzzi, Sergio Alfieri
Published 2021-02-01

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patien...

by Francesca Battaglin, Marta Schirripa, Federica Buggin, Filippo Pietrantonio, Federica Morano, Giorgia Boscolo, Giuseppe Tonini, Eufemia Stefania Lutrino, Jessica Lucchetti, Lisa Salvatore, Alessandro Passardi, Chiara Cremolini, Ermenegildo Arnoldi, Mario Scartozzi, Nicoletta Pella, Luca Boni, Francesca Bergamo, Vittorina Zagonel, Fotios Loupakis, Sara Lonardi
Published 2018-01-01

Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study)

by Maria Alessandra Calegari, Lisa Salvatore, Brunella Di Stefano, Michele Basso, Armando Orlandi, Alessandra Boccaccino, Fiorella Lombardo, Alessandra Auriemma, Ina Valeria Zurlo, Maria Bensi, Floriana Camarda, Marta Ribelli, Raffaella Vivolo, Alessandra Cocomazzi, Carmelo Pozzo, Michele Milella, Maurizio Martini, Emilio Bria, Giampaolo Tortora
Published 2021-04-01

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab.

by Fotios Loupakis, Chiara Cremolini, Dongyun Yang, Lisa Salvatore, Wu Zhang, Takeru Wakatsuki, Pierre Bohanes, Marta Schirripa, Leonor Benhaim, Sara Lonardi, Carlotta Antoniotti, Giuseppe Aprile, Francesco Graziano, Annamaria Ruzzo, Sara Lucchesi, Monica Ronzoni, Ferdinando De Vita, Giuseppe Tonini, Alfredo Falcone, Heinz-Josef Lenz
Published 2013-01-01

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorec...

by Carlotta Antoniotti, Beatrice Borelli, Daniele Rossini, Filippo Pietrantonio, Federica Morano, Lisa Salvatore, Sara Lonardi, Federica Marmorino, Stefano Tamberi, Salvatore Corallo, Giampaolo Tortora, Francesca Bergamo, Di Stefano Brunella, Alessandra Boccaccino, Elisa Grassi, Patrizia Racca, Emiliano Tamburini, Giuseppe Aprile, Roberto Moretto, Luca Boni, Alfredo Falcone, Chiara Cremolini
Published 2020-07-01

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

by Chiara Cremolini, Federica Marmorino, Fotios Loupakis, Gianluca Masi, Carlotta Antoniotti, Lisa Salvatore, Marta Schirripa, Luca Boni, Vittorina Zagonel, Sara Lonardi, Giuseppe Aprile, Emiliano Tamburini, Vincenzo Ricci, Monica Ronzoni, Filippo Pietrantonio, Chiara Valsuani, Gianluca Tomasello, Alessandro Passardi, Giacomo Allegrini, Samantha Di Donato, Daniele Santini, Alfredo Falcone, on behalf of all the investigators of the Gruppo Oncologico del Nord Ovest
Published 2017-06-01

Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

by Alessandro Parisi, Alessio Cortellini, Katia Cannita, Olga Venditti, Floriana Camarda, Maria Alessandra Calegari, Lisa Salvatore, Giampaolo Tortora, Daniele Rossini, Marco Maria Germani, Alessandra Boccaccino, Emanuela Dell’Aquila, Claudia Fulgenzi, Daniele Santini, Michele De Tursi, Nicola Tinari, Pietro Di Marino, Pasquale Lombardi, Susana Roselló Keränen, Marisol Huerta Álvaro, Ina Valeria Zurlo, Domenico Cristiano Corsi, Alessandra Emiliani, Nicoletta Zanaletti, Teresa Troiani, Pasquale Vitale, Riccardo Giampieri, Filippo Merloni, Mario Alberto Occhipinti, Paolo Marchetti, Michela Roberto, Federica Mazzuca, Michele Ghidini, Alice Indini, Ingrid Garajova, Federica Zoratto, Simona Delle Monache, Giampiero Porzio, Corrado Ficorella
Published 2020-05-01